Studies of chest computed tomography (CT) in patients with primary antibody deficiency syndromes (ADS) suggest a broad range of bronchial pathology. However, there are as yet no multicentre studies to assess the variety of bronchial pathology in this patient group. One of the underlying reasons is the lack of a consensus methodology, a prerequisite to jointly document chest CT findings. We aimed to establish an international platform for the evaluation of bronchial pathology as assessed by chest CT and to describe the range of bronchial pathologies in patients with antibody deficiency. Ffteen immunodeficiency centres from 9 countries evaluated chest CT scans of patients with ADS using a predefined list of potential findings including an extent score for bronchiectasis. Data of 282 patients with ADS were collected. Patients with common variable immunodeficiency disorders (CVID) comprised the largest subgroup (232 patients, 82.3%). Eighty percent of CVID patients had radiological evidence of bronchial pathology including bronchiectasis in 61%, bronchial wall thickening in 44% and mucus plugging in 29%. Bronchiectasis was detected in 44% of CVID patients aged less than 20 years. Cough was a better predictor for bronchiectasis than spirometry values. Delay of diagnosis as well as duration of disease correlated positively with presence of bronchiectasis. The use of consensus diagnostic criteria and a pre-defined list of bronchial pathologies allows for comparison of chest CT data in multicentre studies. Our data suggest a high prevalence of bronchial pathology in CVID due to late diagnosis or duration of disease.
Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group / Schütz, Katharina; Alecsandru, Diana; Grimbacher, Bodo; Haddock, Jamanda; Bruining, Annemarie; Driessen, Gertjan; de Vries, Esther; van Hagen, Peter M.; Hartmann, Ieneke; Fraioli, Francesco; Milito, Cinzia; Mitrevski, Milica; Quinti, Isabella; Serra, Goffredo; Kelleher, Peter; Loebinger, Michael; Litzman, Jiri; Postranecka, Vera; Thon, Vojtech; Babar, Judith; Condliffe, Alison M.; Exley, Andrew; Kumararatne, Dinakantha; Screaton, Nick; Jones, Alison; Bondioni, Maria P.; Lougaris, Vassilios; Plebani, Alessandro; Soresina, Annarosa; Sirignano, Cesare; Spadaro, Giuseppe; Galal, Nermeen; Gonzalez-Granado, Luis I.; Dettmer, Sabine; Stirling, Robert; Chapel, Helen; Lucas, Mary; Patel, Smita; Farber, Claire-Michele; Meyts, Isabelle; Banerjee, Arpan K.; Hackett, Scott; Hurst, John R.; Warnatz, Klaus; Gathmann, Benjamin; Baumann, Ulrich. - In: JOURNAL OF CLINICAL IMMUNOLOGY. - ISSN 0271-9142. - 39:1(2019), pp. 45-54. [10.1007/s10875-018-0577-9]
Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group
Fraioli, FrancescoMembro del Collaboration Group
;Milito, CinziaConceptualization
;Mitrevski, Milica;Quinti, IsabellaMembro del Collaboration Group
;Serra, Goffredo;Spadaro, Giuseppe;
2019
Abstract
Studies of chest computed tomography (CT) in patients with primary antibody deficiency syndromes (ADS) suggest a broad range of bronchial pathology. However, there are as yet no multicentre studies to assess the variety of bronchial pathology in this patient group. One of the underlying reasons is the lack of a consensus methodology, a prerequisite to jointly document chest CT findings. We aimed to establish an international platform for the evaluation of bronchial pathology as assessed by chest CT and to describe the range of bronchial pathologies in patients with antibody deficiency. Ffteen immunodeficiency centres from 9 countries evaluated chest CT scans of patients with ADS using a predefined list of potential findings including an extent score for bronchiectasis. Data of 282 patients with ADS were collected. Patients with common variable immunodeficiency disorders (CVID) comprised the largest subgroup (232 patients, 82.3%). Eighty percent of CVID patients had radiological evidence of bronchial pathology including bronchiectasis in 61%, bronchial wall thickening in 44% and mucus plugging in 29%. Bronchiectasis was detected in 44% of CVID patients aged less than 20 years. Cough was a better predictor for bronchiectasis than spirometry values. Delay of diagnosis as well as duration of disease correlated positively with presence of bronchiectasis. The use of consensus diagnostic criteria and a pre-defined list of bronchial pathologies allows for comparison of chest CT data in multicentre studies. Our data suggest a high prevalence of bronchial pathology in CVID due to late diagnosis or duration of disease.File | Dimensione | Formato | |
---|---|---|---|
Schutz_bronchial-patology_2019.docx
accesso aperto
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.1 MB
Formato
Microsoft Word XML
|
1.1 MB | Microsoft Word XML |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.